8-1800000-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000635855.1(KBTBD11-OT1):​n.543+28403A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.843 in 151,990 control chromosomes in the GnomAD database, including 54,675 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.84 ( 54674 hom., cov: 31)
Exomes 𝑓: 1.0 ( 1 hom. )

Consequence

KBTBD11-OT1
ENST00000635855.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.06

Publications

8 publications found
Variant links:
Genes affected
CLN8 (HGNC:2079): (CLN8 transmembrane ER and ERGIC protein) This gene encodes a transmembrane protein belonging to a family of proteins containing TLC domains, which are postulated to function in lipid synthesis, transport, or sensing. The protein localizes to the endoplasmic reticulum (ER), and may recycle between the ER and ER-Golgi intermediate compartment. Mutations in this gene are associated with a disorder characterized by progressive epilepsy with cognitive disabilities (EPMR), which is a subtype of neuronal ceroid lipofuscinoses (NCL). Patients with mutations in this gene have altered levels of sphingolipid and phospholipids in the brain. [provided by RefSeq, Jul 2017]
CLN8 Gene-Disease associations (from GenCC):
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 8
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Orphanet, Ambry Genetics, Myriad Women’s Health
  • neuronal ceroid lipofuscinosis 8 northern epilepsy variant
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • autism spectrum disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.947 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000635855.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KBTBD11-OT1
ENST00000635855.1
TSL:5
n.543+28403A>G
intron
N/AENSP00000489726.1
CLN8
ENST00000636605.1
TSL:5
n.6A>G
non_coding_transcript_exon
Exon 1 of 2
CLN8
ENST00000636934.1
TSL:5
c.544-674A>G
intron
N/AENSP00000490218.1

Frequencies

GnomAD3 genomes
AF:
0.843
AC:
128041
AN:
151870
Hom.:
54618
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.954
Gnomad AMI
AF:
0.913
Gnomad AMR
AF:
0.684
Gnomad ASJ
AF:
0.791
Gnomad EAS
AF:
0.756
Gnomad SAS
AF:
0.797
Gnomad FIN
AF:
0.837
Gnomad MID
AF:
0.820
Gnomad NFE
AF:
0.824
Gnomad OTH
AF:
0.830
GnomAD4 exome
AF:
1.00
AC:
2
AN:
2
Hom.:
1
Cov.:
0
AF XY:
1.00
AC XY:
2
AN XY:
2
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
1.00
AC:
2
AN:
2
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.843
AC:
128151
AN:
151988
Hom.:
54674
Cov.:
31
AF XY:
0.840
AC XY:
62390
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.954
AC:
39585
AN:
41476
American (AMR)
AF:
0.683
AC:
10410
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.791
AC:
2744
AN:
3470
East Asian (EAS)
AF:
0.757
AC:
3881
AN:
5124
South Asian (SAS)
AF:
0.796
AC:
3829
AN:
4808
European-Finnish (FIN)
AF:
0.837
AC:
8844
AN:
10572
Middle Eastern (MID)
AF:
0.813
AC:
239
AN:
294
European-Non Finnish (NFE)
AF:
0.824
AC:
56031
AN:
67972
Other (OTH)
AF:
0.831
AC:
1755
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
968
1937
2905
3874
4842
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
882
1764
2646
3528
4410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.826
Hom.:
37428
Bravo
AF:
0.834
Asia WGS
AF:
0.803
AC:
2791
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.21
DANN
Benign
0.49
PhyloP100
-2.1

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4875960; hg19: chr8-1748166; API